Table 4.
Clinical characteristics of subjects of microarray analysis.
| UA with BSS (n = 5) | Controls (n = 5) | P value | |
|---|---|---|---|
| Male gender (n) | 3 (60%) | 3 (60%) | |
| Age (years) | 61.60 ± 4.93 | 61.00 ± 4.36 | 0.596 |
| BMI (kg/m2) | 23.18 ± 3.89 | 23.24 ± 1.62 | 0.975 |
| Active smoker (n) | 1 (20%) | 1 (20%) | |
| BSS grades | 72.80 ± 10.47 | 0 | |
| Number of vessels (n) | 3.40 ± 0.89 | 0 | |
| Hypertension (n) | 4 (80%) | 0 | 0.048 |
| Type 2 diabetes mellitus (n) | 0 | 0 | |
| Total cholesterol (mmol/L) | 3.96 ± 1.45 | 4.02 ± 0.79 | 0.347 |
| LDL cholesterol (mmol/L) | 2.33 ± 1.01 | 2.51 ± 0.60 | 0.743 |
| HDL cholesterol (mmol/L) | 1.33 ± 0.35 | 1.30 ± 0.30 | 0.874 |
| Triglycerides (mmol/L) | 1.15 ± 0.50 | 1.09 ± 0.34 | 0.815 |
| CRP (mg/L) | 3.64 ± 3.25 | 0.94 ± 0.09 | 0.018 |
| Concurrent medication (n) | |||
| Antiplatelet | 100% | 0 | 0.008 |
| Beta-blocker | 4 (80%) | 0 | 0.048 |
| ACEI/ARB | 4 (80%) | 0 | 0.048 |
| Calcium-channel blockers | 3 (60%) | 0 | 0.167 |
| Nitrates | 4 (80%) | 0 | 0.048 |
| Statin | 4 (80%) | 0 | 0.048 |
Data represents means ± SEM. Abbreviations: ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; BMI: body mass index; BSS: blood stasis syndrome; HDL: high-density protein; CRP: C-reactive protein; LDL: low-density protein.